Pharmacogenetics

Research Frontiers in CYP2C9 Warfarin Interactions and Bleeding Risk

Study of cytochrome P450 2C9 polymorphisms combined with VKORC1 variants to predict warfarin dose requirements and hemorrhagic complications.

All Pharmacogenetics PhD categories